180 Life Sciences to Sell $500M of Common Stock via ATM Offering

180 Life Sciences has filed to sell $500M of common stock through a sales agreement with Clear Street. The company may offer and sell shares of its common stock through Clear Street, acting as its sales agent, or the ATM offering. This move aims to raise capital for the company's operations and growth initiatives.

In a significant move to bolster its financial position and fund growth initiatives, 180 Life Sciences Corp (ATNF) has entered into a sales agreement with Clear Street LLC to potentially sell up to $500 million worth of common stock shares. The company disclosed this arrangement on August 13, 2025, as part of an "at-the-market" offering program [2].

The agreement allows Clear Street to act as the sales agent, facilitating the sale of 180 Life Sciences' common stock on existing trading markets, including the principal market where the company's shares are listed. This move is being made pursuant to a prospectus supplement filed with the Securities and Exchange Commission, which supplements the company’s shelf registration statement that was declared effective on June 26, 2025 [2].

The potential $500 million offering is substantial relative to the company's market capitalization, which could explain the sharp decline in the stock price following the announcement. At-the-market offerings typically allow companies to raise capital incrementally at prevailing market prices, but they can also put downward pressure on stock prices due to the dilution of existing shareholders' equity [2].

Earlier in August, 180 Life Sciences saw a significant increase in its stock price, surging 52.99% in pre-market trading on August 12, 2025, following a $156 million funding round [1]. This funding round aimed to expand the company's Ethereum treasury strategy, boosting its financial strength and blockchain initiatives. Investors view this move as a strategic step to capitalize on Ethereum’s growth in the crypto landscape, positioning 180 Life Sciences as a leader in institutional crypto adoption [1].

The recent stock sale announcement and the potential dilution of shares are likely to be closely watched by investors and financial professionals, as they provide insights into the company's capitalization strategy and its future growth prospects.

References:
[1] https://www.ainvest.com/news/180-life-sciences-corp-atnf-soars-52-99-156m-funding-2508/
[2] https://www.investing.com/news/stock-market-news/180-life-sciences-stock-tumbles-after-announcing-500-million-share-sale-93CH-4192486